Semaglutide (also known as Ozempic for managing Type 2 Diabetes), works by mimicking a gut hormone that causes your pancreas to release insulin, blocks your liver from releasing sugar, and slows down how fast food leaves your stomach
By activating GLP-1 receptors more strongly and for longer, Semaglutide: Reduces appetite and cravings: Signals to the brain that you're full, making it easier to eat smaller portions without feeling deprived Slows gastric emptying: Food stays in your stomach longer, keeping you satisfied between meals Supports stable blood sugar: Improves insulin response and glucose metabolism for better metabolic health Promotes fat loss: When combined with healthy habits, supports loss of body fat while helping preserve lean muscle Clinical studies show patients on Semaglutide can lose 15-20% of their body weight when combined with diet and lifestyle changes, making it one of the most effective non-surgical weight loss options available today
The FDAs approval signifies a new era in the management of this condition, providing healthcare providers with a pharmacological tool to address both weight and sleep apnea simultaneously
Together, they are commonly used to support active weight management and energy protocols
The PIONEER 1-8 clinical studies show that 1.7 to 12% of patients discontinued Rybelsus treatment due to side effects, with gastrointestinal side effects being the most common
